10-K: Cardiff Lexington Corporation's 10-K Filing Reveals Financial Challenges and Strategic Focus on Healthcare Acquisitions

Cardiff Lexington Corporation's 2024 10-K filing highlights a strategic focus on healthcare acquisitions amidst financial challenges, including operating losses and a going concern warning.

Summary

• Cardiff Lexington Corporation's 10-K filing for the fiscal year ended December 31, 2024, reveals a company focused on acquiring undervalued healthcare companies.
• The company operates primarily through its subsidiary, Nova Ortho and Spine, LLC, and also owns a real estate company, Edge View Properties, Inc.
• A key element of the company's strategy is to acquire established profitable niche small to mid-sized healthcare companies, allocating 80% of its acquisition efforts to this area.
• The remaining 20% is targeted towards second-stage startups in healthcare and related financial services.
• The report includes a going concern explanatory paragraph from the independent registered public accounting firm, citing operating losses and negative cash flow.
• The company had an accumulated deficit of $72.9 million as of December 31, 2024, and negative cash flow from operating activities of $5.9 million for the year.
• Management believes that current working capital and expected additional financing will be sufficient to fund operations for at least one year.
• The company's typical accounts receivable collection lifecycle is between 18 and 24 months, creating liquidity and cash flow risks.
• Total revenue decreased by 30.23% to $8.3 million for the year ended December 31, 2024, primarily due to a change in service mix and weather-related facility shutdowns.
• The company identified material weaknesses in its internal control over financial reporting, including a lack of formal documentation and proper segregation of duties.
• The company is undertaking remedial measures to address these weaknesses.
• The company is subject to extensive laws and government regulations in the healthcare industry, including those related to Medicare and Medicaid fraud and abuse.
• The company's real estate business has not generated any revenues to date, except in connection with the sale of three parcels of land in 2021.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there's a strategic focus on healthcare acquisitions, the financial challenges, going concern warning, and internal control weaknesses weigh heavily, resulting in a slightly negative outlook.

Positives

• Management believes current working capital and expected additional financing should be sufficient to fund operations for at least one year.
• The company is implementing enhanced practices to better capture and manage the aging of its billings for accounts receivable.
• The company has a track record of delivering strong growth through a combination of organic growth, new contract additions and selective acquisitions.
• The company is focused on achieving the best clinical outcomes for its patients through the application of rigorous recruiting and credentialing standards.
• The company has dedicated teams with business and clinical expertise that are responsible for implementing best practices.

Negatives

• The company has sustained operating losses since its inception and has an accumulated deficit of $72.9 million as of December 31, 2024.
• The company had negative cash flow from operating activities of $5.9 million for the year ended December 31, 2024.
• The company's typical accounts receivable collection lifecycle is between 18 and 24 months, creating liquidity and cash flow constraints.
• The company lacks systematic processes and resources to support the aging of its accounts receivables.
• The company identified material weaknesses in its internal control over financial reporting.
• The company's healthcare facilities are experiencing the effects of a nationwide staffing shortage, which has caused and may continue to cause an increase in salaries, wages and benefits expense in excess of the inflation rate.

Risks

• The company may not be able to successfully fund acquisitions due to the unavailability of equity or debt financing on acceptable terms.
• The company may experience difficulty as it evaluates, acquires and integrates businesses that it may acquire.
• The company may not be able to effectively integrate the businesses that it acquires.
• The company faces competition for businesses that fit its acquisition strategy.
• The company may change its management and acquisition strategies without the consent of its stockholders.
• The company is a holding company and relies on distributions and other payments from its subsidiaries to meet its obligations.
• The company may engage in a business transaction with one or more target businesses that have relationships with its executive officers or directors, which may create conflicts of interest.
• The operational objectives and business plans of the company's businesses may conflict with its operational and business objectives.
• The company may be deemed to be an investment company under the Investment Company Act.
• The company's ability to grow its business through organic expansion is dependent upon many factors.
• Changes to payment rates or methods of third-party payors could adversely affect the company's operating margins and revenues.
• An increase in uninsured or underinsured patients could harm the company's results of operations.
• Failure to timely or accurately bill for services could have a negative impact on the company's net revenue and cash flow.
• The company's facilities face competition for patients from other healthcare providers.
• The company's performance depends on its ability to recruit and retain quality physicians, nurses and medical support staff.
• If the company does not continually enhance its facilities with the most recent technological advances in diagnostic and surgical equipment, its ability to maintain and expand its markets will be adversely affected.
• If the company fails to comply with extensive laws and government regulations, it could suffer civil or criminal penalties or be required to make significant changes to its operations.
• The company is subject to occupational health, safety and other similar regulations.
• The company may be required to spend substantial amounts to comply with statutes and regulations relating to privacy and security of protected health information.
• State efforts to regulate the construction or expansion of health care facilities could impair the company's ability to expand.
• A cyber security incident could cause a violation of HIPAA, breach of member privacy, or other negative impacts.
• The company may fail to deal with clinical waste in accordance with applicable regulations or otherwise be in breach of relevant medical, health and safety or environmental laws and regulations.
• If any of the company's existing healthcare facilities lose their accreditation or any of its new facilities fail to receive accreditation, such facilities could become ineligible to receive reimbursement under Medicare or Medicaid.
• The company could be subject to lawsuits which could harm the value of its business.
• The company is subject to demand fluctuations in the real estate industry.
• Adverse weather conditions, natural disasters, and other unforeseen conditions could disrupt the company's real estate developments.
• If the market value of the company's real estate investments decreases, its results of operations will also likely decrease.
• Changes in tax laws, taxes or fees may increase the cost of development, and such changes could adversely impact the company's finances and operational results.
• The real estate industry is highly competitive.
• The company may incur environmental liabilities with respect to its real estate assets.
• The company's co-venture partners or other partners in co-ownership arrangements could take actions that decrease the value of its real estate assets.
• Uninsured losses relating to real property or excessively expensive premiums for insurance coverage may adversely affect the value of your stock.
• The company's common stock is eligible for quotation on the Pink Market, which may have an unfavorable impact on its stock price and liquidity.
• The company's common stock may be subject to significant price volatility.
• The company's officers and directors own a significant percentage of its outstanding voting securities which could reduce the ability of minority stockholders to effect certain corporate actions.
• The company has no current plans to pay cash dividends on its common stock for the foreseeable future.
• Future issuances of the company's common stock or securities convertible into its common stock could cause the market price of its common stock to decline and would result in the dilution of your holdings.
• Rule 144 sales in the future may have a depressive effect on the company's stock price.
• Future issuances of debt securities and preferred stock may adversely affect the level of return you may be able to achieve from an investment in the company's common stock.
• If the company's shares of common stock become subject to the penny stock rules, it would become more difficult to trade its shares.
• If securities industry analysts do not publish research reports on the company, or publish unfavorable reports on the company, then the market price and market trading volume of its common stock could be negatively affected.
• The company is subject to ongoing public reporting requirements that are less rigorous than for larger, more established companies, which could make its securities less attractive to investors and may make it more difficult to compare its performance with other public companies.
• Anti-takeover provisions in the company's charter documents and under Nevada law could make an acquisition of its company more difficult, and limit attempts by its stockholders to replace or remove its current management.

Future Outlook

Management believes that current working capital and expected additional financing should be sufficient to fund operations and satisfy obligations for at least one year. The company intends to raise capital for additional acquisitions primarily through equity and debt financings.

Management Comments

• Management estimates that the twelve facilities are operating at 35% capacity as of December 31, 2024.
• Management has invested years working to develop a new and exciting housing development in Salmon, Idaho and plans to enter into a joint venture agreement with a developer for this planned concept development.

Industry Context

The healthcare industry is highly competitive, with increasing competition among healthcare providers for patients and physicians. The company competes with other for-profit healthcare companies, private equity and venture capital firms, as well as not-for-profit entities.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or comparable companies.
• The document does mention competition with other for-profit healthcare companies, private equity and venture capital firms, as well as not-for-profit entities, but does not provide specific details about their performance or metrics.
• The document does not provide any global benchmarks.

Corporate Governance

Legal Proceedings

• The company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.
• The company is not currently aware of any such legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition, or operating results.

Related Party Transactions

• In connection with the acquisition of Edge View on July 16, 2014, the company assumed amounts due to previous owners who are current managers of Edge View.
• The company obtained short-term advances from the Chairman of the Board that are non-interest bearing and due on demand.

Stakeholder Impact

• The company's financial challenges and going concern warning may negatively impact shareholder confidence.
• The company's strategic focus on healthcare acquisitions may create opportunities for growth and value creation for shareholders.
• The company's efforts to improve internal control over financial reporting may enhance the reliability of its financial statements and increase investor confidence.
• The company's compliance with healthcare laws and regulations is critical to maintaining its licenses and certifications and avoiding penalties.
• The company's ability to attract and retain quality physicians, nurses and medical support staff is essential to providing quality patient care.

Next Steps

• The company intends to implement enhanced practices to better capture and manage the aging of its billings for accounts receivable.
• The company intends to complete the remediation of the material weaknesses in its internal control over financial reporting.
• The company intends to raise capital for additional acquisitions primarily through equity and debt financings.

Key Dates